Determining antifungal, anti-biofilm and anticancer activities of “1,3-di(thiophen-2-yl) prop-2- en-1-one” chalcone derivative
Abstract
Objective: Our study aims to determine antifungal and anti-biofilm activity potential of five chalcone derivatives, which have been already reported in the literature, against Candida albicans and Candida tropicalis. In addition, it aimed to determine antioxidant property and anti-cancer activity of 1,3-di(thiophen-2-yl)prop-2-en-1-one chalcone derivative, whose antimicrobial activity was revealed within the study, in human breast cancer cell line (MCF-7) and human bone cancer cell line (MG63).
Method: Chalcones used in the study were diluted two times in dimethyl sulfoxide (DMSO) and prepared at concentration between 1000-15 µg/mL. Antifungal and anti-biofilm activity of chalcones determined by using microdilution method. Radical scavenging activity was tested by employing 2, 2-diphenyl-1-picrylhydrazyl (DPPH). The cell viability was assessed using the cleavage of tetrazolium salts added to the culture medium.
Results: In our study, MIC values of “1,3-di(thiophen-2-yl) prop-2-en-1-one”, which showed its antimicrobial activity on C. albicans and C. tropicalis, were found to be 0.06 mg/mL for both organisms, whereas its MBC values were found to be 0.12 mg/mL and 0.50 mg/mL respectively. MBIC activities were found to be 0.06 and 0.25 mg/mL respectively, whereas MBEC values were found to be 1 mg/mL. When MIC was applied to 48-hours biofilm formation, it was observed that the formation has decreased by 83% and 81%. IC50 value of “1,3-di(thiophen-2-yl) prop-2-en-1-one” was found to be 13,52 µg / mL. Regarding MCF-7 and MG63 cell line at 5 µg / mL concentration, 30% and 65% preserve its viability after 24 hours of incubation respectively.
Conclusions: According to these results, it can be said that chalcone compound that include thiophen ring has shown an inhibiting effect on the multiplication and both on the formation of the biofilm of C. albicans and C. tropicalis strains. The results of the study revealed that chalcone compound may be valuable as an antifungal, anti-biofilm and anti-cancer agent.
Keywords
Kaynakça
- 1. Chandra J, Mukherjee PK. Candida Biofilms: Development, Architecture, and Resistance. Microbiol Spectr 2015; 3: doi: 10.1128/microbiolspec.MB-0020-2015.
- 2. Faria S, Joao I, Jordao J. General overview on nontuberculous mycobacteria, biofilms, and human infection. J Pathog 2015; 2015: 809014.
- 3. Akbari F, Kjellerup BV. Elimination of bloodstream infections associated with Candida albicans biofilm in intravascular catheters. Pathogens 2015; 4: 457-69.
- 4. Tutar U, Çelik C, Ataş M, Tunç T, Gözel MG. Evaluation of biofilm formation activity of standard microorganism strains. J Clin Exp Invest 2015; 6: 135-9.
- 5. Prabodh, CS, Sunil VS, Sandeep J, Dalbir S, Bhojraj S. Synthesis of some new isoxazoline derivatives as possible anti-candida agents. Acta Pol Pharm Drug Res 2009; 66: 101-12.
- 6. El-Hashash MA, Rizk SA, Atta-Allah SR. Synthesis and regioselective reaction of some unsymmetrical heterocyclic chalcone derivatives and spiro heterocyclic compounds as antibacterial agents. Molecules 2015; 20: 22069-83.
- 7. Mukherjee S, Kumar V, Prasad AK, Raj HG, Bracke ME, Olsen CE, Jain SC, Parmar VS. Synthetic and biological activity evaluation studies on novel 1,3-diarylpropenones. Bioorg Med Chem 2001; 9: 337-45.
- 8. Anto RJ, Sukumaran K, Kuttan G, Rao MN, Subbaraju V, Kuttan R. Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Lett 1995; 97: 33-7.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
17 Mayıs 2017
Gönderilme Tarihi
6 Aralık 2016
Kabul Tarihi
21 Mart 2017
Yayımlandığı Sayı
Yıl 2017 Cilt: 39 Sayı: 2